Leukotriene Receptor Ligands
Items 11 to 20 of 20 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 171883 | 88107-10-2 | sc-203120 | 10 mg | $72.00 | ||
LY 171883 is a selective leukotriene receptor ligand known for its unique ability to form stable hydrogen bonds with key amino acid residues in the receptor binding pocket. This interaction facilitates a distinct allosteric modulation of receptor activity, leading to altered signaling pathways. The compound exhibits a favorable lipophilicity, enhancing its membrane permeability and influencing its distribution within cellular environments, thereby affecting downstream biological processes. | ||||||
LY-255283 | 117690-79-6 | sc-201346 sc-201346A sc-201346B | 1 mg 5 mg 50 mg | $102.00 $182.00 $663.00 | 1 | |
LY-255283 is a potent leukotriene receptor ligand characterized by its ability to engage in specific hydrophobic interactions with receptor domains, promoting conformational changes that enhance receptor affinity. Its unique structural features allow for selective binding, which influences the kinetics of receptor activation and desensitization. Additionally, the compound's solubility profile supports its distribution across biological membranes, impacting its interaction dynamics within cellular signaling networks. | ||||||
Verlukast | 120443-16-5 | sc-213152 | 10 mg | $453.00 | ||
Verlukast is a selective leukotriene receptor ligand that exhibits unique binding characteristics through its ability to form hydrogen bonds and hydrophobic contacts with receptor sites. This interaction facilitates a distinct conformational shift in the receptor, modulating downstream signaling pathways. Its molecular design enhances stability and solubility, allowing for efficient membrane permeability and influencing the kinetics of receptor-ligand interactions, thereby affecting cellular response mechanisms. | ||||||
BAY-u 9773 | 154978-38-8 | sc-203835 | 50 µg | $155.00 | ||
BAY-u 9773 functions as a leukotriene receptor ligand, characterized by its ability to engage in specific electrostatic interactions and van der Waals forces with receptor sites. This compound promotes a unique allosteric modulation of receptor activity, influencing the conformational dynamics of the protein. Its structural features contribute to a favorable binding affinity, enhancing the kinetics of receptor activation and subsequent intracellular signaling cascades. | ||||||
Leukotriene B4-dimethyl Amide | 83024-92-4 | sc-200702 | 50 µg | $304.00 | ||
Leukotriene B4-dimethyl Amide acts as a leukotriene receptor ligand, exhibiting a distinctive binding profile that facilitates selective receptor engagement. Its molecular structure allows for intricate hydrogen bonding and hydrophobic interactions, which stabilize the ligand-receptor complex. This compound also influences downstream signaling pathways by modulating receptor desensitization and internalization, thereby affecting cellular responses and enhancing the overall efficacy of leukotriene signaling. | ||||||
FPL 55712 | 40786-08-1 | sc-203583 | 10 mg | $210.00 | ||
FPL 55712 functions as a leukotriene receptor ligand, characterized by its ability to selectively modulate receptor activity through unique conformational changes upon binding. Its structure promotes specific electrostatic interactions and steric effects that enhance receptor affinity. Additionally, FPL 55712 can alter the kinetics of receptor activation, influencing the duration and intensity of signaling cascades, which may lead to varied cellular outcomes in leukotriene-mediated processes. | ||||||
5(S),6(R)-DiHETE | 82948-88-7 | sc-200421 sc-200421A | 50 µg 1 mg | $202.00 $2400.00 | ||
5(S),6(R)-DiHETE acts as a leukotriene receptor ligand, exhibiting a distinct ability to engage with receptor sites through specific hydrophobic interactions and hydrogen bonding. Its unique stereochemistry facilitates selective receptor activation, influencing downstream signaling pathways. The compound's dynamic conformational flexibility allows for rapid modulation of receptor responses, potentially affecting the amplitude and duration of leukotriene signaling events in various biological contexts. | ||||||
LTB3 (Leukotriene B3) | 88099-35-8 | sc-201041 sc-201041B sc-201041A | 50 µg 100 µg 1 mg | $297.00 $480.00 $3579.00 | ||
LTB3 serves as a leukotriene receptor ligand, characterized by its unique ability to form stable complexes with receptor proteins through a combination of hydrophobic and ionic interactions. Its structural conformation enables selective binding, which can modulate receptor activity and influence intracellular signaling cascades. The compound's kinetic profile suggests a rapid association and dissociation with receptors, allowing for fine-tuning of leukotriene-mediated responses in diverse physiological processes. | ||||||
Cinalukast | 128312-51-6 | sc-203893 sc-203893A | 10 mg 50 mg | $224.00 $902.00 | ||
Cinalukast functions as a leukotriene receptor ligand, exhibiting a distinctive binding affinity that is influenced by its specific stereochemistry. The compound engages in intricate molecular interactions, including hydrogen bonding and van der Waals forces, which enhance its selectivity for particular receptor subtypes. Its dynamic conformational flexibility allows for efficient receptor engagement, facilitating nuanced modulation of downstream signaling pathways and cellular responses. | ||||||
14,15-dehydro Leukotriene B4 | 114616-11-4 | sc-205010 sc-205010A | 25 µg 50 µg | $132.00 $232.00 | ||
14,15-dehydro Leukotriene B4 acts as a leukotriene receptor ligand, characterized by its unique structural conformation that promotes selective receptor binding. This compound exhibits a high degree of specificity due to its ability to form stable interactions with receptor sites, including hydrophobic contacts and ionic interactions. Its kinetic profile suggests rapid association and dissociation rates, enabling it to effectively influence cellular signaling cascades and inflammatory responses. | ||||||